HRS-4642 in Combination With Nimotuzumab and Chemotherapy for BRPC With KRAS G12D Mutation
Clinical trial NCT07240766 · RECRUITING
Trial details
- NCT number
- NCT07240766
- Sponsor
- Zhejiang University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-15
- Primary completion
- 2027-05-15
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.